Zelthy Traceability is an AI-powered pharmaceutical supply chain execution platform covering serialised product tracking, distributor management, temperature and cold chain monitoring, and DSCSA, FMD, and CDSCO regulatory compliance. It is positioned not as a passive compliance reporting tool, but as an active execution layer — one that acts on supply chain data in real time rather than simply visualising it. Key capabilities include GS1-compliant serialization, blockchain-powered track-and-trace, and a full Distributor Management System (DMS) with modules for distributor ordering, sales data capture, temperature data capture, and field-level stock management. The platform implemented India's first controlled distribution network for a pharmaceutical product and has reduced stockouts by 15% and improved inventory turnover by 25% in live deployments. Key features and functionalities Zelthy Traceability deploys four AI agents across the supply chain: - an Anomaly Detection Agent that continuously monitors serialization events and distribution data to identify deviations from normal patterns before they escalate; - a Predictive Stockout Agent that analyses inventory levels, order velocity, and seasonal patterns across the distributor network to forecast stockouts 7–14 days in advance; - a Temperature Intelligence Agent that processes real-time IoT cold chain data and uses machine learning to predict time-to-excursion before a temperature breach occurs; - and a Compliance Flagging Agent that monitors DSCSA and FMD reporting deadlines, auto-generates submissions, and flags exceptions for human review. The platform's DMS module provides distributors with a self-service ordering portal, while pharma companies gain visibility into field-level sales data, stock positions, and temperature readings across their entire distribution network. Primary value and solution provided Pharmaceutical supply chain compliance has historically been treated as a cost centre — a necessary investment to avoid regulatory penalties rather than a source of competitive advantage. Zelthy Traceability reframes this by turning the serialization and distribution data that pharma companies are already obligated to collect into an operational intelligence asset. AI agents that predict stockouts two weeks in advance, detect distribution anomalies before they cause recalls, and automate compliance reporting give supply chain and commercial teams a measurable operational edge. For pharma companies operating in markets like India where distribution network complexity is high and manual DMS processes are common, Zelthy delivers this capability without requiring the multi-year SAP implementation programmes that enterprise alternatives demand.